Clinical Trial Update: Repletion of Ergothioneine in Patients With Kidney Failure [NA]

View source ↗

Summary

A Stanford-sponsored clinical trial is evaluating repletion of ergothioneine in patients with end-stage renal disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Ergothioneine (Ergothioneine)

Snippet

Sponsor: Stanford University | Conditions: Esrd | NA | Status: RECRUITING